vimarsana.com

Latest Breaking News On - Urothelial carcinoma - Page 1 : vimarsana.com

TAR-210 results show 90 percent recurrence-free survival

Dr Petrylak on Treatment With Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma

Daniel Petrylak, MD, discusses treatment with enfortumab vedotin plus pembrolizumab in patients with urothelial carcinoma in the community setting.

vimarsana © 2020. All Rights Reserved.